Tumor Cell Proliferation in Esophageal Cancer
Author Information
Author(s): M Sarbia, F Bittinger, R Porschen, P Dutkowski, M Torzewski, R Willers, H E Gabbert
Primary Institution: University of Duisseldorf
Hypothesis
Does the MIB-1 index correlate with the prognosis of esophageal cancer patients?
Conclusion
The MIB-1 index does not provide prognostic information for patients with esophageal cancer.
Supporting Evidence
- The MIB-1 index varied widely among tumors, with a median of 33%.
- No significant correlation was found between the MIB-1 index and various prognostic parameters.
- Survival analysis showed no significant difference between low and high MIB-1 index groups.
Takeaway
This study looked at how fast cancer cells grow in patients with esophageal cancer, but found that it doesn't help predict how well patients will do.
Methodology
Tumor samples from 150 patients were analyzed using immunohistochemistry to count proliferating cells with the MIB-1 antibody.
Limitations
The study did not find significant correlations between the MIB-1 index and established prognostic parameters.
Participant Demographics
121 males and 29 females, median age 58 years (range 35-82 years).
Statistical Information
P-Value
P=0.0001 for mitotic activity correlation.
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website